Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP

BACKGROUND/AIMS: This study was to evaluate the clinical significance of infusion-related reaction (IRR) of rituximab in diffuse large B-cell lymphoma (DLBCL) patients who received R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) as a first-line chemotherapy. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Korean J Intern Med
Main Authors: Cho, Kyoung Min, Keam, Bhumsuk, Ha, Hyerim, Kim, Miso, Jung, Jae-Woo, Song, Woo-Jung, Kim, Tae Min, Jeon, Yoon Kyung, Kang, Hye-Ryun, Kim, Dong-Wan, Kim, Chul Woo, Heo, Dae Seog
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association of Internal Medicine 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6610184/
https://ncbi.nlm.nih.gov/pubmed/29151283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2017.036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados